These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22887956)

  • 1. Burden of de novo malignancy in the liver transplant recipient.
    Chandok N; Watt KD
    Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo malignancies following liver transplantation: impact and recommendations.
    Herrero JI
    Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
    Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
    Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
    Kellerman L; Neugut A; Burke B; Mancini D
    Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo tumors after liver transplantation: a single-institution experience.
    Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
    Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
    Jain AB; Yee LD; Nalesnik MA; Youk A; Marsh G; Reyes J; Zak M; Rakela J; Irish W; Fung JJ
    Transplantation; 1998 Nov; 66(9):1193-200. PubMed ID: 9825817
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
    Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
    Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for cancer after liver transplantation.
    Vallejo GH; Romero CJ; de Vicente JC
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):87-99. PubMed ID: 15979889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of de novo malignancies after liver transplantation.
    Pillai AA
    Transplant Rev (Orlando); 2015 Jan; 29(1):38-41. PubMed ID: 25510578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature.
    Oruc MT; Soran A; Jain AK; Wilson JW; Fung J
    Liver Transpl; 2004 Jan; 10(1):1-6. PubMed ID: 14755771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of de novo tumors after liver transplantation.
    Herrero JI
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1011-6. PubMed ID: 22098062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant malignancies in liver transplant recipients.
    Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer after orthotopic liver transplantation.
    Silva MA; Jambulingam PS; Mirza DF
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.